Alexander B. Sigalov

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “SCHOOL of nature: ligand-independent immunomodulatory peptides”.

SCHOOL of nature: ligand-independent immunomodulatory peptides

Drug Discovery Today(2020)10.1016/j.drudis.2020.05.005

N/A

0.602DataRank · unranked

13 citations

Alexander B. Sigalov

TREM-1 inhibitor specificity and timing of treatment initiation can impact its therapeutic efficacy in cancer and inflammatory disease

Frontiers in Oncology(2025)10.3389/fonc.2025.1689771

N/A

0.104DataRank · unranked

1 citations

Alexander B. Sigalov

Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes

Frontiers in Oncology(2021)10.3389/fonc.2021.734959

N/A

0DataRank · unranked

36 citations

Eric D. Routh, Kip D. Zimmerman, Julia Chifman, Jeff W. Chou, M. Soike +14 more

TREM-1 and TREM-2 as therapeutic targets: clinical challenges and perspectives

Frontiers in Immunology(2024)10.3389/fimmu.2024.1498993

N/A

0DataRank · unranked

8 citations

Alexander B. Sigalov

Pan-TREM-1 versus macrophage-restricted TREM-1 blockade in cancer and other inflammatory pathologies

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.08.22.671865

N/A

0DataRank · unranked

1 citations

Alexander B. Sigalov

SARS-CoV-2 may affect the immune response via direct inhibition of T cell receptor: Mechanistic hypothesis and rationale

OSF Preprints (OSF Preprints)(2021)10.31219/osf.io/37nzm

N/A

0DataRank · unranked

1 citations

Alexander B. Sigalov

Commentary: Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation

Frontiers in Immunology(2020)10.3389/fimmu.2020.00173

N/A

0DataRank · unranked

6 citations

Alexander B. Sigalov